Cambridge engineers new approach for Addenbrooke’s COVID-19 effort
Modelling tools originally designed to improve the efficiency of factories are being used by Cambridge University engineers to help Addenbrooke’s Hospital manage the COVID-19 emergency.
Deployment of the technology has morphed from production lines to hospital wards and from products and raw materials to the flow of patients and supplies.
‘Discrete event simulations’ have been worked up by a team from the University’s Department of Engineering to manage the flow of patients through hospital wards in the event of a surge in cases and anticipate waiting times, bed availability in addition to equipment and staff shortages.
Lead on the simulation development, Dr Ajith Parlikad, of Cambridge’s Institute for Manufacturing, said: “It’s looking at the physical flow of patients and projecting admissions rates into the future – identifying where ‘bottlenecks’ might occur, and where the hospital might need to scale up beds, ventilators, oxygen and staff as part of their COVID-19-orientated activities.
“We started with a flow diagram of how we thought the hospital worked, then talked it through with the team at Addenbrooke’s. It was quite close to their own model but we were able to factor in more details, such as ICU beds, ‘COVID-positive’ beds (patients with the virus who don’t require intensive care), and the initial checking and testing process when patients arrive – everything has a statistical distribution associated with it.”
As well as patient flow modelling, the Department is supporting Addenbrooke’s in a number of other ways. Industrial engineering students are volunteering their time to focus on the hospital’s oxygen supply, among other things how it might be replenished and filtered, and are also looking at how to model and optimise COVID-19 testing processes. Colleagues Tom Ridgman and Florian Urmetzer are co-ordinating the volunteer student group.
Further work is also beginning on modelling that will help the hospital better understand staffing level availability during disruptions such as the COVID-19 outbreak.
Duncan McFarlane, Professor in Industrial Information Engineering, said: “Two weeks ago we knew very little about hospital operations but with close input from the hospital we’ve been able to pick from a series of industrial techniques and apply the most useful ones to this new setting.
“Instead of production lines we’re now looking at hospital wards, and rather than products or raw materials we are examining the flow of patients and supplies.
“The support from the hospital has been extraordinary – especially given the level of pressure it has been operating under.”
Dr Ewen Cameron, Director of Improvement and Transformation at Cambridge University Hospitals, added: “At this time of unprecedented change for the NHS, our teams are working around the clock to set up innovative ways of working to best care for patients and protect our staff.
“The hospital looks very different now to a few weeks ago, and we remain open to additional ideas on how to manage this crisis as best we can.
“New challenges require new ways of thinking, and we are hugely grateful to the Institute for Manufacturing for offering their expertise to help us beat the virus.”
• King’s Lynn company Porvair has also pitched into the coronavirus campaign, doing what it can to help governments and health services. The specialist filtration and environmental technology group is supplying filter components for several of the consortia now building ventilator and breathing apparatus: one in France; one in Sweden; three in the US; and the Mercedes AMG/Formula 1 consortium in the UK.
Porvair is supplying consumables for dozens of US testing laboratories, including the Mayo Clinic; is producing millions of pipette tips for COVID-19 testing kits; and thousands of filters for Diagnostics in the Real World. Shifts have been added to produce chromatography bed supports and pharmaceutical grade water filters.
The board anticipates further programmes will emerge as the crisis continues.
Porvair says it has a strong balance sheet and is expected to be both profitable and modestly cash generative through the balance of the year in all but the most pessimistic scenarios. The board does not believe it needs to change its final dividend recommendation.
Looking at the remainder of 2020, the company anticipates demand in sectors including aviation, automotive and industrial manufacturing to decline. Other sectors, mainly in the Laboratory division, are expected to remain busy.